|
Post by M. Hawbaker on Oct 1, 2021 20:14:00 GMT
(Reuters) -The European Union's drug regulator on Friday identified a possible link between rare cases of blood clotting in deep veins with Johnson & Johnson's COVID-19 vaccine and recommended the condition be listed as a side-effect of the shot. The European Medicines Agency also recommended that immune thrombocytopenia (ITP), a bleeding disorder caused by the body mistakenly attacking platelets, be added as an adverse reaction with an unknown frequency to the J&J vaccine product information and to AstraZeneca's vaccine. J&J said while the chances of experiencing these conditions were very low, the product information would be updated accordingly as it continues to work closely with authorities including EMA. www.yahoo.com/news/eu-finds-j-j-covid-115828405.html
|
|
|
Post by barb43 on Oct 2, 2021 1:07:03 GMT
It's amazing - all of the horrible things that really were not known about these shots before people began receiving them.
|
|